Compositions for the treatment and imaging of stomach and esophageal cancer cells

摘要

A GCC ligand conjugated to a reagent for use in the treatment of stomach or primary and / or metastatic esophageal cancer, where the GCC ligand is a peptide that is less than 25 amino acids long, and where the reagent is selected from a group consisting of: an active enzyme, a chemotherapeutic element, a toxin, a radiotherapeutic element and a radio-sensitizing reagent.